Sleep Disorder Market - Databook 2025 to 2034

The global sleep disorder market size surpassed USD 28,390 million in 2024 and is predicted to reach around USD 88,970 million by 2034, registering a CAGR of 12.1% from 2025 to 2034.

Highlights of the Sleep Disorder Market

• North America dominated the global market in 2024.
• Asia Pacific is anticipated to grow at the fastest rate in the market during the forecast period.
• By disorder type, the sleep apnea segment held a dominant presence in the market in 2024.
• By disorder type, the insomnia segment is expected to grow at the fastest rate in the market during the forecast period of 2025 to 2034.
• By product, the diagnostics segment accounted for a considerable share of the market in 2024.
• By product, the therapeutics segment is projected to experience the highest growth rate in the market between 2025 and 2034.
• By end-user, the hospitals & sleep laboratories segment led the market.
• By end-user, the home care settings & individuals segment is set to experience the fastest rate of market growth from 2025 to 2034.

Industry Valuation and Growth Rate Projection

Sleep disorders are conditions that interfere with normal sleep patterns, causing illnesses like insomnia, sleep apnea, restless legs syndrome, and narcolepsy. Sleep disorders can have a profound effect on the health, productivity, and well-being of an individual. The sleep disorder market leads to diagnosis, treatment, and management of such conditions using a range of products and services such as diagnostic equipment, therapeutic devices, and pharmaceuticals. Technological advancements in the form of AI-enabled CPAP machines and sleep trackers have improved treatment efficiency as well as patient compliance. The market caters to both home and clinic settings, and solutions offered are specific to several needs of patients.

The market for sleep disorders addresses a wide range of applications in various industries. In the healthcare sector, sleep laboratories and hospitals use sophisticated diagnostic tools to detect sleep disorders with high accuracy. Home care environments have witnessed a dramatic rise in the utilization of portable devices, allowing patients to track and control their conditions at home. The pharmaceutical sector also overlaps with the market through the creation of medications for specific sleep disorders. In addition, the adoption of telemedicine has increased access to sleep disorder treatments, especially in rural areas, as the incidence of sleep disorders increases across the world. The market continues to expand, responding to the increasing need for effective solutions.

• In the US, almost 50 to 70 million adults are experiencing sleep disorders, where about 30% of the adult population across the globe suffers from insomnia. The spreading prevalence fuels the demand for successful diagnosis and treatment.
• Advances in the form of AI-based diagnostic systems and intelligent therapeutic devices have enhanced treatment efficiency and patient compliance. For example, the advancement of portable machines to monitor sleep and wearable sensors has increased sleep disorder management convenience and accessibility.

Sleep Disorder Market: Stats and Figures

• 50 to 70 million Americans have chronic sleep disorders such as insomnia, sleep apnea, and restless leg syndrome.
• The worldwide sleep health business is worth an estimated US$ 30 to 40 billion and includes a broad spectrum of products and services intended to enhance sleep quality.
• Prevalence of narcolepsy has increased by 14% in recent years from 38.9 per 100,000 in 2013 to 44.3 per 100,000 in 2016, showing rising recognition and diagnosis.

How AI has Benefited the Market

• AI algorithms scan sophisticated sleep data to identify anomalies and possible sleep disorders, like insomnia or sleep apnea, for more precise diagnosis.
• AI applications create customized treatment plans from patient-specific information, improving treatment effectiveness and patient adherence.
• AI technologies allow for noninvasive, real-time monitoring of sleep patterns, enabling early identification of sleep disturbances and accompanying health conditions.
• AI performs labor-intensive tasks such as sleep study scoring, offloading clinician workload, and making sleep clinics more efficient.

Industry Leader Announcements (50 words)

• Advancements in AI and wearable technology are revolutionizing how we diagnose and manage sleep disorders, opening new avenues for personalized treatments.
• The growing awareness of sleep health is driving demand for innovation solutions, and we see tremendous potential for market expansion in the coming years.

Geographical Insights

North America

The North American region led the sleep disorder market across the world in 2023 with a tremendous market share due to several factors. Growing awareness regarding sleep disorders, along with a high prevalence rate of sleep disorders such as insomnia and sleep apnea, has led to increased demand for diagnosis and treatment. Moreover, the fact that some of the major market players have a presence in countries like the US and that there is proper healthcare infrastructure available within the country has been at the forefront in driving market growth. Government initiatives such as investments in research for sleep disorder therapy and technological advancements in medical devices have also been the reason behind the leadership of the region.

Asia Pacific

Asia Pacific is expected to witness the highest growth rate in the future, with a predicted highest CAGR of 2024-2034. The rapid economic growth, coupled with the rising incidence of sleep disorders, primarily in China’s and Japan’s aged population, is a key driver for growth. With growing medical awareness, more and more individuals are coming forward to be cured of sleeping disorders, thus making demand for sleep disorder therapies on a proportionate basis. Lifestyle issues and urbanization are growing in these areas as well and are acting as a contributing factor in making sleeping issues worse, raising demand for sleep disorder treatments.

China

China is the crème de la crème of the Asian Pacific nations and the primary force behind market growth. The country’s sizeable and aging population is driving a sleep disease boom, and it’s a good market for sleep disorder treatment. Moreover, China’s growing healthcare sector, driven by medical technology and innovation expenditures, has led to increased availability and accessibility of treatments. Government spending on healthcare innovations and the adoption of state-of-the-art technologies have made China a leader in the regional sleep disorder market. Therefore, growing Chinese interest in healthcare places it among the major drivers of the future of the industry.

Recent Developments in the Sleep Disorder Market:

• The global sleep apnea devices market reached a valuation of USD 6.64 billion in 2024 and is projected to attain approximately USD 12.39 billion by 2023, growing at a CAGR of 7% this growth is driven by the increasing prevalence of sleep disorders, heighted awareness of sleep health issues, and advancements in diagnostic and therapeutic technologies.
• The global sleep tech devices market was valued at USD 24.85 billion in 2024 and is expected to reach around USD 134.60 billion by 2034, expanding at a CAGR of 18.46%. This surge is attributed to the growing demand for wearable sleep tracking devices, increased consumer awareness about sleep health, and rapid technological advancement in sleep monitoring solutions.

Competitive Landscape

The international sleep disorder industry is moderately fragmented, with dominance by a small number of market leaders like ResMed and many more. They hold strong market positions through the large portfolios of products they have their widespread presence.

• Company Name: ResMed Inc
• Year of Incorporation: 1989
• Headquarters: San Diego, California, USA

ResMed develops CPAP, ventilators, and cloud-connected software to treat sleep apnea and chronic respiratory conditions. It operates in over 140 countries and is a global leader in digital health solutions. ResMed has made notable investments in AI-driven patient monitoring and home-based therapy optimization.

• Company Name: Philips Healthcare
• Year of Incorporation: 1891
• Headquarters: Amsterdam, Netherlands

A major player in sleep and respiratory care, Philips offers CPAP/ BiPAP machines and oxygen therapy devices. Despite recent product recalls, it remains strong globally and is actively enhancing its sleep therapy tech through AI and user-centered design. It’s a part of Royal Philips.

• Company Name: Fisher and Paykel Healthcare
• Year of Incorporation: 1934
• Headquarters: Auckland, New Zealand

Specializing in respiratory and acute care, F&P is renowned for its humidification-based sleep therapy systems and neonatal care products.